Repotrectinib is a type of kinase inhibitor that’s been made just for treating ROS1-positive NSCLC and NTRK-fusion cancers. It goes after a bunch of kinases linked to cancer growth and spread, making it a versatile cancer fighter. You can get it as 40 mg capsules, and they usually come in bottles with 60 capsules.
The recommended dosage for repotrectinib is initially 160 mg administered once daily for the first 14 days, followed by a maintenance dose of 160 mg taken twice daily. You can take it with or without eating.
